GlobeNewswire

SolarWinds Extends Network Management Software Leadership with Deeper Visibility and Smarter Scalability

Dela

Software now simplifies management of complex networks with Network Insight for Cisco Nexus and intelligent mapping, supporting environments four times larger than previous generation

AUSTIN, Texas, May 23, 2018 (GLOBE NEWSWIRE) -- SolarWinds, the worldwide leader in network management software, today announced a wave of updates to its network management product portfolio, which can now support networks up to four times larger than the previous generation. This significant gain makes it easy to consolidate monitoring solutions to a single provider enterprise-wise, and gives IT professionals far greater flexibility to scale up and support larger data center networks as workloads increase, or scale out to address complex distributed networks. 

SolarWinds says the broad refresh of its network management portfolio strengthens its IDC®-validated network management leadership position.1 Updated versions of Network Performance Monitor (NPM), Network Configuration Manager (NCM), IP Address Manager (IPAM), NetFlow Traffic Analyzer (NTA), and VoIP & Network Quality Manager (VNQM) are now available.

"In the hybrid IT world, networks are growing larger, more complex, and more distributed, making them even more challenging to manage and troubleshoot," said Christoph Pfister, executive vice president of products, SolarWinds. "This is a big reason why over half of enterprise IT professionals in our SolarWinds 2018 IT Trends Report said they do not feel as confident in their IT environment's performance as their mid-size and small business counterparts."

"By quadrupling scalability and deepening visibility, SolarWinds network management software will give IT professionals unprecedented flexibility to evolve easily as their networks expand and spread out. It also offers the power to manage networks simply, comprehensively, and accurately, all without compromising our industry-leading affordability," he added. "As recently confirmed for the third year in a row, we believe our position as highest in ability to execute in the 2018 Gartner® Magic Quadrant® for Network Performance Monitoring and Diagnostics2 reinforces our commitment to helping organizations meet their network management needs today, regardless of their size."

Navigating the Complexity of Today's Networks

The updated SolarWinds® network management portfolio features three breakthroughs designed to further improve visualization and speed troubleshooting across the complex and distributed networks at the foundation of today's hybrid IT environments. 

  • First, the four-fold increase in monitoring capacity allows IT professionals to accelerate and simplify their network management process while reducing the resources needed for monitoring activities, making it easier to consolidate tools.  
     
  • Second, the latest software adds intelligent, auto-generating, and contextually-aware maps that enable faster and clearer visualization of network performance. These powerful capabilities enable IT professionals to quickly identify issues and speed time-to-resolution when troubleshooting. 
     
  • Third, SolarWinds is introducing Network Insight(TM) for Cisco Nexus®, the latest Network Insight, which already includes support for F5® and Cisco® ASA. Adding support for Cisco Nexus bridges a huge gap in data center performance visibility with in-depth analyses that go beyond basic hardware health and statistics.

    This feature gives IT professionals a quick view of the landscape and any bottlenecks. It presents data in a simplified functional model, so that everyone on the IT staff can achieve expert-level insights on Nexus performance regardless of proficiency level. By embracing Cisco Nexus hardware, this new Network Insight also underscores the SolarWinds commitment to enabling superior device-specific visibility for environments of all sizes.

"The Network Insight for Cisco Nexus feature is doing a lot to help us monitor our environment much more effectively," said Josh Haberman, Network Engineer, Veolia North America, the world's leading provider of environmental solutions. "There really is a need for deeper visibility and this latest offering from SolarWinds clearly shows us what is happening in the network," he added. "The scalability improvements were also an unexpected surprise. It's reassuring to have the extra capacity as we plan for the future."

Further, the enhanced network management portfolio builds on other SolarWinds innovations such as NetPath(TM), which provides a "hop-by-hop" analysis of network performance across hybrid IT landscapes and into the public cloud. Recently, SolarWinds began deployment of NetPath onto its Managed Service Provider (MSP) platforms, providing another way to access this powerful technology regardless of how they monitor their environments. This important migration underscores the ongoing commitment made by a worldwide leader in network monitoring and management to extending the powerful benefits of its technology and expertise beyond its core customer base of IT practitioners and into the growing legions of all professionals who manage IT environments.

New Versions across the Network Management Portfolio

Within its network management portfolio, SolarWinds announced updates to the following software products.

  • Network Performance Monitor (NPM) 12.3 - Along with Network Insight for Cisco Nexus, including detailed visibility into virtual Port Channels (vPCs), the latest version of NPM provides superior network monitoring capabilities and detailed visibility for multi-vendor environments.
     
  • Network Configuration Monitor (NCM) 7.8 - The updated version brings even stronger automation and control of network functions and, like NPM, adds Network Insight for Cisco Nexus switches. It provides configuration snippets and the ability to filter, search, and view access control lists (ACLs), including object groups, and Virtual Device Context (VDC) support. 
     
  • IP Address Manager (IPAM) 4.7 - A valuable tool that automates management of IP addresses, the latest version now automates IP requests and monitors hybrid environments with Amazon® Route53 and Azure® DNS support.
     
  • NetFlow Traffic Analyzer (NTA) 4.4 - With a new Flow Storage SQL database at its foundation and less-demanding CPU and IOPS requirements, the new version offers IT professionals significantly improved speed and performance in identifying network traffic issues and removing bottlenecks, while providing better security.
     
  • VoIP and Network Quality Manager (VNQM) 4.5 - The latest version of VNQM adds support for monitoring of SIP trunks, enabling users to manage voice quality and performance across networks using the latest VoIP technologies.

Pricing and Availability

The updated SolarWinds network management portfolio, including Network Insight for Cisco Nexus, will be available starting on May 30, 2018. SolarWinds NPM pricing starts at $2,955*; SolarWinds NCM pricing starts at $2,895*; SolarWinds IPAM pricing starts at $1,995*; SolarWinds NTA pricing starts at $1,915*; and SolarWinds VNQM pricing starts at $1,615*.

SolarWinds will publicly demonstrate its updated network management portfolio for the first time at Cisco Live!® in Orlando, Fla., starting on June 10. The SolarWinds booth number is 1259.

For more information, visit the SolarWinds website , or call 866.530.8100.

*Prices as of May 30, 2018 in US Dollars. Pricing may vary based upon the jurisdiction and applicable currency. Please contact a local SolarWinds sales representative to find pricing specific to your jurisdiction.

Additional Resources

Connect with SolarWinds

1 Source: IDC-defined Network Management Software functional market. IDC's Worldwide Semiannual Software Tracker®, April 2018

2 Source: Gartner, "Magic Quadrant for Network Performance Monitoring and Diagnostics," Sanjit Ganguli, Vivek Bhalla, Pankaj Prasad, 21 February 2018.

Gartner Disclaimer 
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About SolarWinds

SolarWinds provides powerful and affordable IT management software to customers worldwide, from Fortune 500® enterprises to small businesses, managed service providers (MSPs), government agencies, and educational institutions. We are committed to focusing exclusively on IT, MSP, and DevOps professionals, and strive to eliminate the complexity that our customers have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain, and scale while providing the power to address key areas of the infrastructure from on-premises to the cloud. This focus and commitment to excellence in end-to-end hybrid IT performance management has established SolarWinds as the worldwide leader in both network management software and MSP solutions, and is driving similar growth across the full spectrum of IT management software. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks of) their respective companies.

© 2018 SolarWinds Worldwide, LLC. All rights reserved.

       
MEDIA CONTACTS:      
Nicole Fachet     Jenne Barbour
Text100     SolarWinds
Phone: 212.871.3950     Phone: 512.498.6804
NicoleF@text100.com     pr@solarwinds.com
       

Photos accompanying this announcement are available at: 

http://www.globenewswire.com/NewsRoom/AttachmentNg/a0ee85af-57cd-4e57-bd2a-4ad2a67e33c9

http://www.globenewswire.com/NewsRoom/AttachmentNg/95179026-6b4d-4b9c-b791-f769421162ff




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum